CVRx, Inc. financial data

Symbol
CVRX on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
9201 West Broadway Avenue, Suite 650, Minneapolis, Minnesota
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.32 K % -22.5%
Quick Ratio 135 % +45.7%
Debt-to-equity 40.6 % +241%
Return On Equity -66.1 % -75.2%
Return On Assets -47 % -39.4%
Operating Margin -126 % +25.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21.6 M shares +4.27%
Common Stock, Shares, Outstanding 21.6 M shares +4.27%
Entity Public Float 190 M USD +163%
Common Stock, Value, Issued 216 K USD +4.35%
Weighted Average Number of Shares Outstanding, Basic 21.2 M shares +2.6%
Weighted Average Number of Shares Outstanding, Diluted 21.2 M shares +2.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 42.1 M USD +59.6%
Cost of Revenue 6.54 M USD +21.7%
Research and Development Expense 11.3 M USD +1.48%
Operating Income (Loss) -53.2 M USD -18.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -51.9 M USD -21.5%
Income Tax Expense (Benefit) 151 K USD +29.1%
Net Income (Loss) Attributable to Parent -52 M USD -21.5%
Earnings Per Share, Basic -2.48 USD/shares -19.2%
Earnings Per Share, Diluted -1.04 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 80.1 M USD -22.4%
Accounts Receivable, after Allowance for Credit Loss, Current 8.5 M USD +32%
Inventory, Net 11.1 M USD +34.2%
Assets, Current 102 M USD -15.1%
Property, Plant and Equipment, Net 2.55 M USD +41.2%
Operating Lease, Right-of-Use Asset 1.27 M USD +360%
Other Assets, Noncurrent 26 K USD -3.7%
Assets 106 M USD -13.5%
Accounts Payable, Current 2.61 M USD +30.7%
Employee-related Liabilities, Current 270 K USD
Accrued Liabilities, Current 5.79 M USD -2.87%
Liabilities, Current 8.4 M USD +5.54%
Operating Lease, Liability, Noncurrent 1.09 M USD +1751%
Other Liabilities, Noncurrent 1.15 M USD +41.1%
Liabilities 39.9 M USD +73.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -210 K USD -2.94%
Retained Earnings (Accumulated Deficit) -500 M USD -11.6%
Stockholders' Equity Attributable to Parent 66.3 M USD -33.5%
Liabilities and Equity 106 M USD -13.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.9 M USD -6.31%
Net Cash Provided by (Used in) Financing Activities 1.36 M USD -82%
Net Cash Provided by (Used in) Investing Activities -917 K USD -282%
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 21.6 M shares +4.27%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.5 M USD -258%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80.1 M USD -22.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 770 K USD +310%
Deferred Tax Assets, Valuation Allowance 111 M USD +8.56%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 111 M USD +8.56%
Operating Lease, Liability 1.33 M USD +365%
Depreciation 524 K USD +9.4%
Payments to Acquire Property, Plant, and Equipment 917 K USD +282%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52 M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid 1.54 M USD +421%
Property, Plant and Equipment, Gross 5.47 M USD +30.2%
Operating Lease, Liability, Current 239 K USD +5.29%
Lessee, Operating Lease, Liability, to be Paid, Year Two 362 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 350 K USD +194%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 211 K USD +2010%
Lessee, Operating Lease, Liability, to be Paid, Year Three 374 K USD
Deferred Tax Assets, Operating Loss Carryforwards 89.2 M USD +8.68%
Unrecognized Tax Benefits 2.22 M USD +8.55%
Lessee, Operating Lease, Liability, to be Paid, Year Four 223 K USD
Operating Lease, Payments 100 K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 15.7 M USD +228%
Interest Expense 2.52 M USD +522%